Aster DM Healthcare (ASTERDM) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
3 Jun, 2026Strategic vision and values
Committed to accessible, affordable quality healthcare with a global vision and strong core values of excellence, respect, compassion, passion, integrity, and unity.
Business overview and operational scale
Operates 20 hospitals with 5,449 beds across 16 cities and 5 states, supported by 10 clinics, 304 labs, and 203 pharmacies as of March 2026.
Achieved 61% occupancy, 3.1 days average length of stay, and INR 51,800 ARPOB in FY26.
Revenue reached INR 4,643 Cr in FY26, with a 3-year CAGR of 16% and operating EBITDA margin of 20.4%.
Merger with Quality Care India Limited (QCIL)
Approved merger with QCIL, creating one of India's top 3 hospital chains with 10,623 beds and INR 9,273 Cr revenue.
Merged entity, Aster DM Quality Care Limited, will have 57.3% Aster and 42.7% QCIL shareholding.
Merger is cash neutral, expected to be EPS accretive from the first full year, and jointly controlled by Aster promoters and Blackstone.
Latest events from Aster DM Healthcare
- Record net profit and EPS in Q1 FY25, driven by GCC business sale and strong India growth.ASTERDM
Q1 24/259 Jul 2026 - Double-digit revenue and profit growth, margin expansion, and strong outlook in H1 FY25.ASTERDM
Q2 24/258 Jul 2026 - Q2 FY26 delivered strong growth, margin expansion, hospital launches, and QCL merger progress.ASTERDM
Q2 25/268 Jul 2026 - Merger forms a top-three Indian hospital chain with 10,150+ beds, strong synergies, and Blackstone backing.ASTERDM
M&A Announcement8 Jul 2026 - 15% YoY revenue and 22% EBITDA growth, merger progress, and internal restructuring marked Q3FY26.ASTERDM
Q3 25/268 Jul 2026 - FY25 revenue up 12%, EBITDA margin at 19.5%, QCIL merger and major one-time gains boost results.ASTERDM
Q4 24/258 Jul 2026 - Aster DM and QCIL merge to form a top 3 Indian hospital chain with 10,150+ beds and strong growth.ASTERDM
Investor Presentation18 Jun 2026 - Strong growth in revenue, capacity, and clinical excellence, with major expansion plans ahead.ASTERDM
Investor Presentation18 Jun 2026 - Robust revenue and EBITDA growth, with the Quality Care merger and expansion fueling future gains.ASTERDM
Q4 25/261 May 2026